Cargando…
MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay
PURPOSE: We exploited the MassARRAY (MA) genotyping platform to develop the “PTC-MA assay”, which allows the simultaneous detection of 13 hotspot mutations, in the BRAF, KRAS, NRAS, HRAS, TERT, AKT1, PIK3CA, and EIF1AX genes, and six recurrent genetic rearrangements, involving the RET and TRK genes...
Autores principales: | Pesenti, Chiara, Muzza, Marina, Colombo, Carla, Proverbio, Maria Carla, Farè, Claudia, Ferrero, Stefano, Miozzo, Monica, Fugazzola, Laura, Tabano, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997117/ https://www.ncbi.nlm.nih.gov/pubmed/29214440 http://dx.doi.org/10.1007/s12020-017-1483-2 |
Ejemplares similares
-
Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011) -
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
por: Colombo, Carla, et al.
Publicado: (2021) -
Combined Mutational and Clonality Analyses Support the Existence of Intra-Tumor Heterogeneity in Papillary Thyroid Cancer
por: Muzza, Marina, et al.
Publicado: (2021) -
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology
por: Ibarrola-Villava, Maider, et al.
Publicado: (2016) -
MassArray analysis of genomic susceptibility variants in ovarian cancer
por: Verma, Sonali, et al.
Publicado: (2020)